Onassis Holdings Launches $75 Million Regulation A+ Financing Round with Dalmore Group

Biotech company Onassis Holdings has initiated a Regulation A+ financing round through Dalmore Group, enabling public investment of up to $75 million annually to advance its epigenetic rejuvenation technologies.

September 15, 2025
Onassis Holdings Launches $75 Million Regulation A+ Financing Round with Dalmore Group

Onassis Holdings (OTC: ONSS), a biotechnology holding company focused on longevity and rejuvenation technologies, has announced the launch of a Regulation A+ financing round through an agreement with Dalmore Group. This financing initiative allows the company to raise up to $75 million annually from public investors, providing significant capital to advance its epigenetic reprogramming technologies.

The partnership with Dalmore Group brings substantial expertise to the financing effort, as the firm has onboarded more than 270 Regulation A+ issuers since 2021 and possesses over 16 years of experience in the market. Dalmore provides comprehensive support services including marketing and public relations assistance, marketplace syndication, and secondary trading solutions for issuers participating in Regulation A+ offerings.

Onassis Holdings operates through its subsidiary Ananda Labs, which focuses on developing groundbreaking therapies based on patented proteins designed to rejuvenate elderly cells while maintaining their distinct biological properties. The company's work in epigenetic reprogramming represents an emerging frontier in biotechnology that could potentially address age-related diseases and extend human healthspan.

The Regulation A+ financing structure represents an important development in capital markets accessibility, allowing smaller companies to raise funds directly from the public while providing investors with opportunities to participate in early-stage biotechnology innovation. This approach democratizes investment in cutting-edge medical research that was traditionally accessible only to institutional investors or venture capital firms.

For additional information about the company's technology and research focus, visit https://www.onassis-holdings.com/. The full details of the financing announcement can be found at https://ibn.fm/s9HOQ.